The conference was well attended by a diverse audience of investors and provided great visibility for Colorado bioscience companies."
- Timothy Rodell M.D., President & CEO, GlobeImmune
The Rocky Mountain Life Science Investor Conference offered a valuable opportunity for Inviragen to meet with new potential investors and continue discussions with previous contacts. Biotech success is linked to investment and the RMLIPC brought together interested investors with active biotech companies in the Mountain States region. Inviragen is pleased to have participated in the conference and looks forward to participating again.”
- Dan Stinchcomb, President & CEO, Inviragen, Inc.